Primary Hyperaldosteronism (DBCOND0041635)

Identifiers

Synonyms
Conns Syndrome / Conn's Syndrome / Conn Syndrome / Primary hyperaldosteronism / Idiopathic aldosteronism (disorder) / Primary hyperaldosteronism (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Canrenoic acid
An aldosterone antagonist used in primary hyperaldosteronism and other disorders related to aberrant aldosterone levels.
No drug targets
Spironolactone
An aldosterone receptor antagonist used to treat edema, hypertension, heart failure, and aldosteronism.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05456997
Metabolic Myopathy in EndocrinopathyNo drug interventionsNot AvailableNot Availableterminated
NCT01567111
11C-Metomidate PET Versus Adrenal Vein Sampling in Primary AldosteronismNo drug interventionsdiagnosticNot Availablecompleted
NCT03474237
A Prospective Cohort Study for Patients With Adrenal DiseasesNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01978132
Primary Hyperaldosteronism and Ischemia-reperfusion InjuryNo drug interventionsdiagnosticNot Availablecompleted
NCT02934399
Dynamic Hormone Diagnostics in Endocrine DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04251780
Tissue K+ in Primary HyperaldosteronismNo drug interventionsdiagnosticNot Availablerecruiting
NCT05636995
HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial)No drug interventionsNot AvailableNot Availablerecruiting
NCT04556279
Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.Not AvailableNot Availablewithdrawn
NCT05640128
Determination of Threshold Values of Aldosterone in HPLC-MS/MS, of Renin and of the Aldosterone / Renin Ratio for the Diagnosis of Primary HyperaldosteronismNo drug interventionsdiagnosticNot Availablerecruiting
NCT01728493
Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00732771
Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronismtreatment2completed
NCT03155139
Primary Aldosteronism In Hypertensive Patients in ChinaNo drug interventionsNot AvailableNot Availablecompleted
NCT03405025
Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing AdenomasNo drug interventionsotherNot Availablecompleted
NCT01761344
Intraoperative Analysis of Cortisol During Adrenal Vein SamplingNo drug interventionsdiagnosticNot Availablecompleted
NCT04278404
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Not AvailableNot Availablerecruiting
NCT02938910
Study of Myocardial Interstitial Fibrosis in HyperaldosteronismNo drug interventionsNot AvailableNot Availablecompleted
NCT01959711
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic AdrenalectomyNo drug interventionstreatment4completed
NCT00669266
Adrenal Tumors - Pathogenesis and TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02030587
Laparoscopic Adrenalectomy Versus Radiofrequency AblationNo drug interventionstreatmentNot Availableunknown_status